Tubiana Lab- Machine Learning for Computational Structural Biology & Protein Design

The Tubiana Lab leverage advanced machine learning and statistical physics to decode complex biological structures and engineer functional proteins. By developing generative AI models and data-driven computational algorithms, the lab accelerates biotherapeutic discovery, enabling the rational design of custom proteins and molecular interactions with high specificity.

Research Focus

  • Computational Structural Biology: Applying statistical physics and machine learning to model protein structures, dynamics, and molecular interactions at atomic resolution.
  • AI-Driven Protein Design: Developing generative artificial intelligence models to design novel functional proteins, enzymes, and therapeutic scaffolds from scratch.
  • Machine Learning for Biomolecules: Building specialized deep learning and statistical inference frameworks to analyze large-scale biological datasets and predict molecular function.

Capabilities

  • Generative AI & Machine Learning Modeling: Custom machine learning architectures tailored for biomolecular sequence, structure, and interaction predictions.
  • Statistical Physics & Computational Frameworks: Physical-statistical modeling methods to evaluate protein stability, folding landscapes, and conformational changes.
  • In-Silico High-Throughput Screening: Computational pipelines for rapid screening and optimization of candidate protein leads prior to experimental synthesis.

Partnership & Opportunities in Different Industries

  • Biopharma & Therapeutic Protein Discovery: Partnering with biotechnology and pharmaceutical companies to design novel antibody candidates, peptide drugs, and targeted protein therapeutics.
  • Industrial & Synthetic Biology: Collaborating with agtech and industrial biotech partners to engineer custom enzymes and biocatalysts with enhanced stability and activity.
  • Software & Computational Bio Tools: Licensing proprietary machine learning algorithms and computational tools to life science software and platform companies.
  • Potential Market Segments: ICT & Media (Machine learning & AI), Therapeutics (Drug Discovery, Bioconvergence), Research Tools (Research Software), Synthetic Biology.

Selected Publications

  • Generative models and statistical physics approaches for protein sequence and structure modeling – Demonstrating machine learning frameworks for predicting structural conformations and functional mutations.
  • Machine learning architectures for de novo protein design – Outlining data-driven computational strategies to design novel, stable protein geometries for biomedical applications.

Contact:

Email: jeromet@tauex.tau.ac.il

 

Sign up for
our events

    Close
    Life Science
    Magazine

      Close
      Hi-Tech
      Magazine

        Close